118743-81-0

Basic information

• Product Name: (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT
• Synonyms: (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT;(R)-N-(α-Methylbenzyl)hydroxylaMine oxalate salt;N-[(1R)-1-Phenylethyl]hydroxylamine oxalate salt;N-[(1R)-1-Phenylethyl]hydroxylamine: oxalic acid;N-[(1R)-1-Phenylethyl]hydroxylamine
• CAS NO: 118743-81-0
• Molecular Formula: C₂H₂O₄*C₈H₁₁NO
• Molecular Weight: 227.22
• Mol File: 118743-81-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT(CAS DataBase Reference)
• NIST Chemistry Reference: (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT(118743-81-0)
• EPA Substance Registry System: (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT(118743-81-0)

Safety Data

• Hazard Codes: C
• Statements: 22-34
• Safety Statements: 26-36/37/39-45
• RIDADR: UN 3261 8 / PGIII
• WGK Germany: 3
• Hazardous Substances Data: 118743-81-0(Hazardous Substances Data)

Usage

General Description

The chemical (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT, also known as rasagiline mesylate, is a medication used to treat Parkinson's disease. (ALPHAR)-N-HYDROXY-ALPHA-METHYL-BENZENEMETHANAMINE ETHANEDIOATE SALT is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor, which works by increasing levels of dopamine in the brain. It is typically taken orally and is well-absorbed by the body. Rasagiline mesylate has been shown to improve motor symptoms and reduce "off" time in patients with Parkinson's disease. It is also being studied for its potential neuroprotective and disease-modifying effects. Common side effects may include headache, joint pain, nausea, and insomnia.

Downstream Products

• 195196-19-1 C₄₁H₆₁NO₄Si₂ 
• 195196-15-7 (3S,4S)-4-hydroxy-3-phenyl-N-(1-phenylethyl)isoxazolidinone 
• 862107-62-8 N-[1-(tert-butyldiphenylsilanyloxymethyl)-4-trityloxy-2-butenyl]-N-(1R)-(1-phenylethyl)-hydroxylamine 
• 862107-63-9 N-[1-(tert-butyldiphenylsilanyloxymethyl)-4-trityloxy-2-butenyl]-N-(1R)-(1-phenylethyl)amine 
• 357154-20-2 N-[(1R)-phenylethyl]-C-ethoxycarbonylnitrone 
• 127001-34-7 N-Benzylidene<(R)-(-)-α-methylbenzyl>amine N-oxide 
• 121614-03-7 (1R)-N-<<(4S)-2,2-dimethyl-1,3-dioxolan-4-yl>methylene>-1-phenylethylamine N-oxide 
• 125506-98-1 (2Z)-{oxido[(1R)-1-phenylethyl]imino}ethanoic acid 
• 118743-82-1 N-<4-(Benzyloxycarbonylamino)butylidene>-(R)-(-)-α-methylbenzylamine N-oxide 
• 125507-00-8 C₁₁H₁₃NO₃ 
• 862107-60-6 C₂₆H₃₁NO₂Si 
• 129508-07-2 (S)-5-Chloro-3-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-((R)-1-phenyl-ethyl)-isoxazolidine-5-carbonitrile 
• 129508-06-1 (S)-2-((R)-1-Phenyl-ethyl)-3-((S)-2-thioxo-[1,3]dioxolan-4-yl)-isoxazolidin-5-one 
• 129508-02-7 (S)-3-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-2-((R)-1-phenyl-ethyl)-isoxazolidin-5-one